Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Polymorphism of Doxazosin Mesylate

  • Published : 2005.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Nine polymorphic modifications of doxazosin mesylate have been obtained by recrystallization in organic solvents under variable conditions. Different polymorphs of doxazosin mesylate were characterized by powder X-ray crystallography diffractometry (PXRD), differential scanning calorimetry (DSC), and thermogravimetric analysis (TG). Transformation of Form 1 and Form 2 was not occurred in three relative humidities ($0\%$, $51\%$, and $99\%$) at 20$\pm$0.5 for 30 days.

Keywords

References

  1. Borka, L., Reviews on crystal polymorphism of substances in the European Pharmacopoeia. Pharm. Acta Helv., 66, 16-22 (1991)
  2. Giron, D., Thermal analysis and calorimetric methods in the characterization of polymorphs and solvates. Thermochim. Acta, 248, 1-59 (1995) https://doi.org/10.1016/0040-6031(94)01953-E
  3. Grcman, M., Vrecer, F., and Meden, A., Some physico-chemical properties of Doxazosin mesylate polymorphic forms and its amorphous state. J. Therm. Anal. Cal., 68, 373-387 (2002) https://doi.org/10.1023/A:1016019214704
  4. Giridhar, T., Reddy, R. B.. and Ramesh, C., Methods for the preparation of polymorphs of doxazosin mesylate. US 6,399,775 B1 (2002)
  5. Gruenenberg, A., Polymorphie und thermische Analyse pharmazeutischer Wirkstoffe. Pharmazie in unserer Zeit, 26, 224-231 (1997) https://doi.org/10.1002/pauz.19970260506
  6. Haleblian, J. and McCrowne, W., Pharmaceutical applications of polymorphism. J. Pharm. Sci., 58, 911-929 (1969) https://doi.org/10.1002/jps.2600580802
  7. Haleblian, J., Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J. Pharm. Sci., 64, 1269-1288 (1975) https://doi.org/10.1002/jps.2600640805
  8. Kuhnert-Brandstaetter, M., Polymorphie von Arzneistoffen und ihre Bedeutung in der pharmazeutischen Technologie. Informationsdienst A.P.V., 19, 73-90 (1973)
  9. Sohn, Y. T., Effect of polymorphism on bioavailability of amoxicillin. Yakhak Hoeji, 39, 438-443 (1995)
  10. Sohn, Y. T. and Kim, S. Y., Effect of crystal form on in vivo topical anti-inflammatory activity of corticosteroids. Arch. Pharm. Res., 25, 556-559 (2002) https://doi.org/10.1007/BF02976618
  11. Sun, C. and Grant, D. J. W., Influence of crystal structure on the tableting properties of sulfamerazine polymorphs. Pharm. Res., 18, 274-280 (2001) https://doi.org/10.1023/A:1011038526805
  12. Yoshinari, T., Forbes, R. T., York, P., and Kawashima, Y., The improved compaction properties of mannitol after a moistureinduced polymorphic transition. Int. J. Pharm., 258, 121-131 (2003) https://doi.org/10.1016/S0378-5173(03)00157-1